Stephan W. Morris

16.3k citations

120 papers · 12.0k indexed · 2 hit papers · h-index 52

Impact in

Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Oncology top 0.5%
- Viral-associated cancers and disorders
- Lung Cancer Research Studies

Papers in

Pathology and Forensic Medicine 48
- Lymphoma Diagnosis and Treatment 46
Genetics 24
- Chronic Lymphocytic Leukemia Research 23

Co-authors: Mark N. Kirstein David N. Shapiro A. Thomas Look Marcus B. Valentine David L. Saltman Zhigui Ma Liquan Xue Justus Duyster
Journals: Blood (24 papers)Journal of Biological Chemistry (7 papers)Genomics (6 papers)Journal of Clinical Oncology (6 papers)Oncogene (6 papers)
Partner nations: United States Germany China

In The Last Decade

Stephan W. Morris

117 papers receiving 11.7k citations

Hit Papers

align trajectories log scale

Matrix Stiffness–Induced Myofibroblast Differentiation Is Mediated by Intrinsic Mechanotransduction 2012 · 406 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 American Journal of Respiratory Cell and Molecular Biology
1994 Science

Peers

Countries citing papers authored by Stephan W. Morris

Since Specialization

Citations

This map shows the geographic impact of Stephan W. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan W. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan W. Morris more than expected).

Fields of papers citing papers by Stephan W. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan W. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan W. Morris. The network helps show where Stephan W. Morris may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephan W. Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephan W. Morris Line = papers co-authored together Stephan W. Morris links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Complete remission of <i>NUP98</i> fusion-positive acute myeloid leukemia with the covalent menin inhibitor BMF-219, icovamenib Haematologica ·Hetty E. Carraway, Joy Nakitandwe, Alexandru Cacovean, Yan Ma, Brian Munneke, Ganesh Waghmare, Clarissa Mandap, Uzma Ahmed, Nicole Kowalczyk, Thomas W. Butler, Stephan W. Morris	2024	5
2	CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells The Journal of Immunology ·Yongwei Zheng, Mei Yu, Yuhong Chen, Liquan Xue, Wen Zhu, Guoping Fu, Stephan W. Morris, Renren Wen, Demin Wang	2023	1
3	A β2-Integrin/MRTF-A/SRF Pathway Regulates Dendritic Cell Gene Expression, Adhesion, and Traction Force Generation Frontiers in Immunology ·Carla Guenther, Imrul Faisal, Liisa M. Uotila, Marc Llort Asens, Heidi Harjunpää, Terhi Savinko, Tiina Öhman, Sean Yao, Markus Moser, Stephan W. Morris, Sari Tojkander, Susanna C. Fagerholm	2019	23
4	Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer Cancer Discovery ·Jim Sang, Jaime Acquaviva, Julie C. Friedland, Donald L. Smith, Manuel Sequeira, Chaohua Zhang, Qin Jiang, Liquan Xue, Christine M. Lovly, John-Paul Jimenez, Alice T. Shaw, Robert C. Doebele, Suqin He, Richard C. Bates, D. Ross Camidge, Stephan W. Morris, Iman El‐Hariry, David A. Proia	2013	174
5	Matrix Stiffness–Induced Myofibroblast Differentiation Is Mediated by Intrinsic Mechanotransduction American Journal of Respiratory Cell and Molecular Biology ·Xiangwei Huang, Naiheng Yang, Vincent F. Fiore, Thomas H. Barker, Yi Sun, Stephan W. Morris, Qiang Ding, Victor J. Thannickal, Yong Zhou Hit paper breakdown →	2012	406
6	A Case of Primary Cutaneous Senile EBV-Related Diffuse Large B-Cell Lymphoma American Journal of Dermatopathology ·Blanca Garrido Martín, Sean Whittaker, Stephan W. Morris, Alistair Robson	2010	11
7	Cell Type-Specific Regulation of ITAM-Mediated NF-κB Activation by the Adaptors, CARMA1 and CARD9 The Journal of Immunology ·Hiromitsu Hara, Chitose Ishihara, Arata Takeuchi, Liquan Xue, Stephan W. Morris, Josef Penninger, Hiroki Yoshida, Takashi Saito	2008	49
8	The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors Nature Immunology ·Hiromitsu Hara, Chitose Ishihara, Arata Takeuchi, Takayuki Imanishi, Liquan Xue, Stephan W. Morris, Masanori Inui, Toshiyuki Takai, Akira Shibuya, Shinobu Saijo, Yoichiro Iwakura, Naohito Ohno, Haruhiko Koseki, Hiroki Yoshida, Josef Penninger, Takashi Saito	2007	272
9	B Cell Lymphoma 10 Is Essential for FcεR-Mediated Degranulation and IL-6 Production in Mast Cells The Journal of Immunology ·Yuhong Chen, Bhanu P. Pappu, Hu Zeng, Liquan Xue, Stephan W. Morris, Xin Lin, Renren Wen, Demin Wang	2007	24
10	Multisite Phosphorylation of Nuclear Interaction Partner of ALK (NIPA) at G2/M Involves Cyclin B1/Cdk1 Journal of Biological Chemistry ·Florian Bassermann, Christine von Klitzing, Anna Lena Illert, Silvia Münch, Stephan W. Morris, Michele Pagano, Christian Peschel, Justus Duyster	2007	23
11	Bcl10 plays a critical role in NF-κB activation induced by G protein-coupled receptors Proceedings of the National Academy of Sciences ·Donghai Wang, Yun You, Pei-Chun Lin, Liquan Xue, Stephan W. Morris, Hu Zeng, Renren Wen, Xin Lin	2006	80
12	NIPA Defines an SCF-Type Mammalian E3 Ligase that Regulates Mitotic Entry Cell ·Florian Bassermann, Christine von Klitzing, Silvia Münch, Ren-Yuan Bai, Hiroyuki Kawaguchi, Stephan W. Morris, Christian Peschel, Justus Duyster	2005	61
13	The oncogenic fusion protein nucleophosmin–anaplastic lymphoma kinase (NPM–ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model Oncogene ·Cornelius Miething, Rebekka Grundler, Falco Fend, Josef Hoepfl, Claudia Mugler, Christoph von Schilling, Stephan W. Morris, Christian Peschel, Justus Duyster	2003	34
14	Diversity of Genomic Breakpoints in TFG-ALK Translocations in Anaplastic Large Cell Lymphomas American Journal Of Pathology ·Luís Hernández, Sı́lvia Beà, Beatríz Bellosillo, Magda Pinyol, Brunangelo Falini, Antonino Carbone, German Ott, Andreas Rosenwald, Alberto Fernández, Karen Pulford, David Y. Mason, Stephan W. Morris, Eugenio Santos, Elı́as Campo	2002	76
15	Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma The Journal of Immunology ·Qian Zhang, Puthryaveett N. Raghunath, Liquan Xue, Mirosław Majewski, David Carpentieri, Niels Ødum, Stephan W. Morris, Tomasz Skórski, Mariusz A. Wasik	2002	220
16	Molecular features of B-cell lymphoma Current Opinion in Oncology ·Reiner Siebert, Andreas Rosenwald, Louis M. Staudt, Stephan W. Morris	2001	42
17	Anaplastic Lymphoma Kinase (ALK) is not Expressed in Hodgkin's Disease: Results with ALK-11 Antibody in 327 Untreated Patients Leukemia & lymphoma ·Marco Herling, George Z. Rassidakis, Simonetta Viviani, V. Bonfante, Riccardo Giardini, Massimo Gianni, Stephan W. Morris, Fernando Cabanillas, L. Jeffrey Medeiros, Andreas H. Sarris	2001	14
18	Expression of the ALK Tyrosine Kinase Gene in Neuroblastoma American Journal Of Pathology ·Laurence Lamant, Karen Pulford, Daniela Bischof, Stephan W. Morris, David Y. Mason, Georges Delsol, Bernard Mariamé	2000	168
19	The Genes Encoding the Eph-Related Receptor Tyrosine Kinase Ligands LERK-1 (EPLG1, Epl1), LERK-3 (EPLG3, Epl3), and LERK-4 (EPLG4, Epl4) Are Clustered on Human Chromosome 1 and Mouse Chromosome 3 Genomics ·Douglas Pat Cerretti, Stewart D. Lyman, Carl J. Kozlosky, Neal G. Copeland, Debra J. Gilbert, Nancy A. Jenkins, Virginia Valentine, Mark N. Kirstein, David N. Shapiro, Stephan W. Morris	1996	11
20	Assignment of the Human MAD and MXI1 Genes to Chromosomes 2p12-p13 and 10q24-q25 Genomics ·David N. Shapiro, Virginia Valentine, Linette R. Eagle, Xiaoying Yin, Stephan W. Morris, Edward V. Prochownik	1994	34

About Stephan W. Morris

Stephan W. Morris is a scholar working on Pathology and Forensic Medicine, Genetics, Hematology, Oncology and Immunology, having authored 120 papers that have together received 12.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (23 papers), Lung Cancer Treatments and Mutations (20 papers), Immune Cell Function and Interaction (14 papers), Acute Myeloid Leukemia Research (11 papers), Viral-associated cancers and disorders (10 papers), Immune Response and Inflammation (9 papers) and NF-κB Signaling Pathways (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.5k citations), Oncology (3.9k citations), Genetics (1.4k citations), Immunology (2.2k citations) and Cancer Research (1.4k citations). Stephan W. Morris has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Mark N. Kirstein, David N. Shapiro, A. Thomas Look, Marcus B. Valentine, David L. Saltman, Zhigui Ma, Liquan Xue, Justus Duyster, Ren-Yuan Bai and Stanley Pounds. Their work appears in journals such as Blood, Journal of Biological Chemistry, Genomics, Journal of Clinical Oncology and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact